Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,314 | -4,283 | N/A | N/A |
| Depreciation Amortization | 575 | 196 | N/A | N/A |
| Accounts receivable | -1,779 | -416 | N/A | N/A |
| Accounts payable and accrued liabilities | 132 | 150 | N/A | N/A |
| Other Working Capital | -1,748 | -323 | N/A | N/A |
| Other Operating Activity | 10,165 | 279 | 0 | 0 |
| Operating Cash Flow | $-969 | $-4,397 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,030 | -731 | N/A | N/A |
| Other Investing Activity | -175 | -49 | 0 | 0 |
| Investing Cash Flow | $-2,205 | $-780 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 3,500 | 4,000 | N/A | N/A |
| Financing Cash Flow | $3,500 | $4,000 | $N/A | $N/A |
| Beginning Cash Position | 172 | 1,349 | N/A | N/A |
| End Cash Position | 498 | 172 | N/A | N/A |
| Net Cash Flow | $326 | $-1,177 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -969 | -4,397 | N/A | N/A |
| Capital Expenditure | -2,100 | -731 | N/A | N/A |
| Free Cash Flow | -3,069 | -5,128 | 0 | 0 |